Activity value 70the republic of congo Buyer,Last transaction date:
2020-05-29
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for roffe pharma from 2019 to 2020.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2020, the company has completed 41 transactions, with a transaction quantity of 61569 and a transaction weight of 0.
YearTransactionsQuantityWeight
2019165367758.90
202041615690
Bill of lading data
<
1/15
>
Trade date
2020/05/29
B/L No.
kc4m6bpb7m8jz
Suppliers
novaarc
Buyers
roffe pharma
POLs
——
PODs
——
Supply area
India
Purchas area
The Democratic Republic Of The Congo
Weight
——
Amount
2098.599
Hs code
30049059
Product tags
s tablet,artemether,lumefantrine
roffe pharma is the republic of congo Buyer,
and primarily engages in the import and export business of products such as ail,mg tablet,tin.
According to the 52wmb.com global trade database, as of 2020-05-29, the company has completed 1500 international trades,
with its main trading regions covering india etc.
The core products include HS30049099,HS30041030,HS30049087 etc,
often transported via pointe noire,port douala, port bangui etc,
and its main trading partners are novaarc,astro international,salvavidas pharmaceutical pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on roffe pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.